- Home
- SBFM vs RELI Comparison
SBFM vs RELI Comparison
Compare SBFM & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- RELI
- Stock Information
- Founded
- SBFM 2006
- RELI 2013
- Country
- SBFM United States
- RELI United States
- Employees
- SBFM N/A
- RELI N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- RELI Specialty Insurers
- Sector
- SBFM Health Care
- RELI Finance
- Exchange
- SBFM Nasdaq
- RELI Nasdaq
- Market Cap
- SBFM 6.7M
- RELI 7.5M
- IPO Year
- SBFM N/A
- RELI N/A
- Fundamental
- Price
- SBFM $1.75
- RELI $0.90
- Analyst Decision
- SBFM Strong Buy
- RELI
- Analyst Count
- SBFM 1
- RELI 0
- Target Price
- SBFM $7.00
- RELI N/A
- AVG Volume (30 Days)
- SBFM 71.9K
- RELI 9.0M
- Earning Date
- SBFM 11-04-2025
- RELI 11-06-2025
- Dividend Yield
- SBFM N/A
- RELI N/A
- EPS Growth
- SBFM N/A
- RELI N/A
- EPS
- SBFM N/A
- RELI N/A
- Revenue
- SBFM $36,341,741.00
- RELI $14,061,478.00
- Revenue This Year
- SBFM $32.20
- RELI N/A
- Revenue Next Year
- SBFM $32.74
- RELI N/A
- P/E Ratio
- SBFM N/A
- RELI N/A
- Revenue Growth
- SBFM 19.22
- RELI 1.07
- 52 Week Low
- SBFM $1.17
- RELI $0.67
- 52 Week High
- SBFM $3.90
- RELI $5.11
- Technical
- Relative Strength Index (RSI)
- SBFM 66.08
- RELI 46.86
- Support Level
- SBFM $1.50
- RELI $0.97
- Resistance Level
- SBFM $1.74
- RELI $1.06
- Average True Range (ATR)
- SBFM 0.09
- RELI 0.11
- MACD
- SBFM 0.01
- RELI 0.00
- Stochastic Oscillator
- SBFM 96.84
- RELI 36.68
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.